font size
Sign in

REVIEW / PREVIEW:

G. Steven Burrill Issues Annual Predictions for Biotech Industry

Focus to shift from promise to execution in 2015


As the end of 2014 approaches, a year of unprecedented financial activity and dealmaking for the biotechnology industry, biotech visionary G. Steven Burrill issued his annual predictions for the life sciences in the new year.
Read More
Todays Stories
Podcast Therapeutic Vaccine for Parkinson's Disease Shows Early Promise

Kuldip Dave, director of research programs for the Michael J. Fox Foundation, discusses encouraging early-stage results for Affiris' experimental therapeutic vaccine for Parkinson's, what the results tell us, and why alpha-synuclein may be a compelling target in the fight against Parkinson’s disease.

By the numbers Pharmas Tap Academia for Drug Discovery



Non-traditional partnering deals have become the norm over the past few years as Big Pharma has shifted its resources away from internal R&D to outsourcing innovation. Such was the case over the past week as Bristol-Myers Squibb and Astellas Pharma partnered to access biopharmaceutical innovation coming out of academia and research institutes.